1 – 5 of 5
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
(
- Contribution to journal › Article
- 2020
-
Mark
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk
2020) In Journal of Human Hypertension(
- Contribution to journal › Article
-
Mark
Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease
(
- Contribution to journal › Article
-
Mark
The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue
(
- Contribution to journal › Article
- 2011
-
Mark
Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans
(
- Contribution to journal › Article